dr. jain on treatment options for patients with myelofibrosis who progress after transplant
Published 4 years ago • 355 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:54
dr. jain on challenges with allogeneic transplant in myelofibrosis
-
1:14
treating gvhd in patients with myelofibrosis following transplant
-
0:43
dr. jain on high-risk mutations in myelofibrosis
-
4:30
myelofibrosis: considerations for transplant or surgery
-
1:51
dr. jain on gvhd from allogeneic stem cell transplant
-
5:54
treating intermediate/high-risk primary myelofibrosis
-
1:30
dr. snyder on tools to improve use of allogeneic stem cell transplant in myelofibrosis
-
2:57
selecting patients with myelofibrosis for allosct: molecular, patient & transplant-related factors
-
16:10
stem cell transplant for myelofibrosis in the jak2 inhibitor era
-
21:52
stem cell transplant for myelofibrosis in the jak2 inhibitor era
-
1:51
dr. snyder on transplant updates in myelofibrosis
-
5:10
what are the treatment options for myelofibrosis?
-
1:31
the role of haploidentical transplantation in myelofibrosis
-
4:20
primary myelofibrosis: risk stratification
-
2:09
approved & emerging jak inhibitors for patients with high-risk mf who are transplant-ineligible
-
4:44
transplantation in patients with myelofibrosis
-
0:45
unmet needs that remain for patients with al amyloidosis who fail frontline treatment
-
7:11
treatment of older mds patients with bmt (bone marrow transplantation)
-
1:42
early allogeneic transplantation for myelofibrosis patients responding to ruxolitinib